In addition, genetic inhibition of CBP promoted cell differentiation and p53-dependent cell senescence in chronic myeloid leukemia independent of BCR-ABL status [44]. Here, CREBBP is linked to chronic myelogenous leukemia, BCR-ABL1 positive.